|
1
|
Noutsios GT and Floros J: Childhood
asthma: Causes, risks, and protective factors; a role of innate
immunity. Swiss Med Wkly. 144:w140362014.PubMed/NCBI
|
|
2
|
Asher MI, Montefort S, Björkstén B, Lai
CK, Strachan DP, Weiland SK and Williams H; ISAAC Phase Three Study
Group, : Worldwide time trends in the prevalence of symptoms of
asthma, allergic rhinoconjunctivitis, and eczema in childhood:
ISAAC Phases One and Three repeat multicountry cross-sectional
surveys. Lancet. 368:733–743. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Marco R, Cappa V, Accordini S, Rava M,
Antonicelli L, Bortolami O, Braggion M, Bugiani M, Casali L,
Cazzoletti L, et al: Trends in the prevalence of asthma and
allergic rhinitis in Italy between 1991 and 2010. Eur Respir J.
39:883–892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zuyderduyn S, Sukkar M, Fust A, Dhaliwal S
and Burgess JK: Treating asthma means treating airway smooth muscle
cells. Eur Respir J. 32:265–274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hirst SJ, Martin JG, Bonacci JV, Chan V,
Fixman ED, Hamid QA, Herszberg B, Lavoie JP, McVicker CG, Moir LM,
et al: Proliferative aspects of airway smooth muscle. J Allergy
Clin Immunol. 114(2 Suppl): S2–S17. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carlin SM, Roth M and Black JL: Urokinase
potentiates PDGF-induced chemotaxis of human airway smooth muscle
cells. Am J Physiol Lung Cell Mol Physiol. 284:L1020–L1026. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Madison JM: Migration of airway smooth
muscle cells. Am J Respir Cell Mol Biol. 29:8–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parameswaran K, Radford K, Zuo J, Janssen
L, O'byrne P and Cox P: Extracellular matrix regulates human airway
smooth muscle cell migration. Eur Respir J. 24:545–551. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Le Luduec JB, Condamine T, Louvet C,
Thebault P, Heslan JM, Heslan M, Chiffoleau E and Cuturi MC: An
immunomodulatory role for follistatin-like 1 in heart allograft
transplantation. Am J Transplant. 8:2297–2306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esterberg R, Delalande JM and Fritz A:
Tailbud-derived Bmp4 drives proliferation and inhibits maturation
of zebrafish chordamesoderm. Development. 135:3891–3901. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ouchi N, Oshima Y, Ohashi K, Higuchi A,
Ikegami C, Izumiya Y and Walsh K: Follistatin-like 1, a secreted
muscle protein, promotes endothelial cell function and
revascularization in ischemic tissue through a nitric-oxide
synthase-dependent mechanism. J Biol Chem. 283:32802–32811. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chan QK, Ngan HY, Ip PP, Liu VW, Xue WC
and Cheung AN: Tumor suppressor effect of follistatin-like 1 in
ovarian and endometrial carcinogenesis: A differential expression
and functional analysis. Carcinogenesis. 30:114–121. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Miller M, Beppu A, Rosenthal P, Pham A,
Das S, Karta M, Song DJ, Vuong C, Doherty T, Croft M, et al: Fstl1
promotes asthmatic airway remodeling by inducing oncostatin M. J
Immunol. 195:3546–3556. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geng Y, Dong Y, Yu M, Zhang L, Yan X, Sun
J, Qiao L, Geng H, Nakajima M, Furuichi T, et al: Follistatin-like
1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling
antagonist in controlling mouse lung development. Proc Natl Acad
Sci USA. 108:pp. 7058–7063. 2011; View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong Y, Geng Y, Li L, Li X, Yan X, Fang Y,
Li X, Dong S, Liu X, Li X, et al: Blocking follistatin-like 1
attenuates bleomycin-induced pulmonary fibrosis in mice. J Exp Med.
212:235–252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnston I, Spence HJ, Winnie JN, McGarry
L, Vass JK, Meagher L, Stapleton G and Ozanne BW: Regulation of a
multigenic invasion programme by the transcription factor, AP-1:
Re-expression of a down-regulated gene, TSC-36, inhibits invasion.
Oncogene. 19:5348–5358. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sumitomo K, Kurisaki A, Yamakawa N,
Tsuchida K, Shimizu E, Sone S and Sugino H: Expression of a
TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human
lung cancer cell lines. Cancer Lett. 155:37–46. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei Y, Xu YD, Yin LM, Wang Y, Ran J, Liu
Q, Ma ZF, Liu YY and Yang YQ: Recombinant rat CC10 protein inhibits
PDGF-induced airway smooth muscle cells proliferation and
migration. Biomed Res Int. 2013:6909372013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu W, Kong H, Zeng X, Wang J, Wang Z, Yan
X, Wang Y, Xie W and Wang H: Iptakalim inhibits PDGF-BB-induced
human airway smooth muscle cells proliferation and migration. Exp
Cell Res. 336:204–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ning Y, Huang H, Dong Y, Sun Q, Zhang W,
Xu W and Li Q: 5-Aza-2-deoxycytidine inhibited PDGF-induced rat
airway smooth muscle cell phenotypic switching. Arch Toxicol.
87:871–881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Day RM, Lee YH, Park AM and Suzuki YJ:
Retinoic acid inhibits airway smooth muscle cell migration. Am J
Respir Cell Mol Biol. 34:695–703. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee JH, Johnson PR, Roth M, Hunt NH and
Black JL: ERK activation and mitogenesis in human airway smooth
muscle cells. Am J Physiol Lung Cell Mol Physiol. 280:L1019–L1029.
2001.PubMed/NCBI
|
|
24
|
Xie S, Sukkar MB, Issa R, Oltmanns U,
Nicholson AG and Chung KF: Regulation of TGF-beta 1-induced
connective tissue growth factor expression in airway smooth muscle
cells. Am J Physiol Lung Cell Mol Physiol. 288:L68–L76. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burgess JK, Lee JH, Ge Q, Ramsay EE,
Poniris MH, Parmentier J, Roth M, Johnson PR, Hunt NH, Black JL and
Ammit AJ: Dual ERK and phosphatidylinositol 3-kinase pathways
control airway smooth muscle proliferation: Differences in asthma.
J Cell Physiol. 216:673–679. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stewart AG, Xia YC, Harris T, Royce S,
Hamilton JA and Schuliga M: Plasminogen-stimulated airway smooth
muscle cell proliferation is mediated by urokinase and annexin A2,
involving plasmin-activated cell signalling. Br J Pharmacol.
170:1421–1435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oshima Y, Ouchi N, Sato K, Izumiya Y,
Pimentel DR and Walsh K: Follistatin-like 1 is an Akt-regulated
cardioprotective factor that is secreted by the heart. Circulation.
117:3099–3108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Movassagh H, Shan L, Halayko AJ, Roth M,
Tamm M, Chakir J and Gounni AS: Neuronal chemorepellent Semaphorin
3E inhibits human airway smooth muscle cell proliferation and
migration. J Allergy Clin Immunol. 133:560–567. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Walker TR, Moore SM, Lawson MF, Panettieri
RA Jr and Chilvers ER: Platelet-derived growth factor-BB and
thrombin activate phosphoinositide 3-kinase and protein kinase B:
Role in mediating airway smooth muscle proliferation. Mol
Pharmacol. 54:1007–1015. 1998.PubMed/NCBI
|
